Keyphrases
Acetylcholinesterase Inhibitors (AChEI)
8%
Acne
12%
Active Rheumatoid Arthritis
8%
Acupuncture
20%
Adjuvant Chemotherapy
8%
Adult Hearing Loss
8%
Adverse Effects
13%
Adverse Events
29%
Analgesic Efficacy
7%
Antipsychotics
26%
Assessment Development
9%
Attention Deficit Hyperactivity Disorder
12%
Atypical Antipsychotics
14%
Azelaic Acid
8%
Basal Insulin
12%
Between-group
7%
Cancer Pain
12%
China
15%
Chinese Herbal Medicine
8%
CINAHL
6%
Clinical Practice Guidelines
11%
Cochrane
30%
Cochrane Review
15%
Cochrane Systematic Review
12%
Cognitive Behavioral Therapy
8%
Comparative Efficacy
8%
Concurrent Chemoradiotherapy
8%
Confidence Interval
100%
Consensus Guidance
8%
Continuous Data
7%
Conventional Hearing Aid
8%
COVID-19
9%
Dance Therapy
8%
Delirium
8%
Dichotomous Data
6%
Dose-ranging
7%
Embase
16%
Evaluation Assessment
9%
Evidence-based Clinical Practice Guideline
12%
Extracted Data
9%
Fruit Acidity
8%
Ginkgo Biloba
8%
Global State
7%
Grading of Recommendations
9%
Hearing Aids
7%
Hydromorphone
12%
Hydroxy Acids
5%
Induction Chemotherapy
8%
Inter-rater Reliability
10%
International Consensus
8%
Listening Devices
8%
Maintenance Dose
6%
MEDLINE
17%
Mental States
9%
Meta-analysis
35%
Methylphenidate
8%
Network Meta-analysis
14%
Neuropathic Pain
8%
Nicotinamide
8%
Non-randomized Studies of Interventions
5%
Nonrandomized Studies
8%
Number-needed-to-treat
11%
Optimal Maintenance
6%
People with Schizophrenia
22%
Pharmacological Intervention
13%
Physical Health Care
6%
Placebo
31%
Preadolescent children
8%
Psychoeducation
12%
Psychosis
6%
PsycINFO
5%
PubMed
7%
Quality of Life
13%
Quetiapine
6%
Randomized Clinical Trial
9%
Randomized Controlled Trial
61%
Randomized Trial
8%
Recurrent Nasopharyngeal Carcinoma
8%
Relative Risk
13%
Review Authors
11%
Risk of Bias
26%
Risk of Bias Tool
5%
Risk Ratio
55%
Risperidone
11%
Salicylic Acid
8%
Schizophrenia
94%
Search Methods
10%
Search Strategy
6%
Selection Criteria
13%
Severe Mental Illness
16%
Sulfur Acid
8%
Systematic Meta-analysis
29%
Systematic Survey
8%
Tinnitus
12%
Tolerability
8%
Topical Treatment
6%
Tripterygium Wilfordii
8%
Type 2 Diabetes Mellitus (T2DM)
12%
Typical Antipsychotics
7%
Zinc
8%
Pharmacology, Toxicology and Pharmaceutical Science
2 Hydroxyacid
5%
Acne
8%
Adverse Event
41%
Antipsychotic
20%
Attention Deficit Disorder
8%
Atypical Antipsychotics
14%
Azelaic Acid
8%
Cancer Pain
12%
Chemoradiation Therapy
12%
Chemotherapy
8%
Cholinesterase Inhibitor
8%
Clinical Trial
5%
Clozapine
5%
Controlled Clinical Trial
5%
Delirium
8%
Disease
10%
Ginkgo Biloba
8%
Group Trial
6%
Hydromorphone
12%
Infection
6%
Nasopharynx Carcinoma
8%
Negative Syndrome
5%
Nicotinamide
8%
Non Insulin Dependent Diabetes Mellitus
8%
Number Needed to Treat
10%
Overall Survival
5%
Placebo
30%
Quetiapine
6%
Randomized Clinical Trial
10%
Randomized Controlled Trial
81%
Rheumatoid Arthritis
8%
Risperidone
11%
Salicylic Acid
8%
Sulfur
8%
Symptom
10%
Tinnitus
12%
Tolerability
8%
Tripterygium wilfordii
8%
Typical Antipsychotic
19%
Medicine and Dentistry
2 Hydroxyacid
5%
Acneiform Eruption
12%
Adolescent
8%
Adverse Event
15%
Attention Deficit Disorder
8%
Auriculotherapy
20%
Azelaic Acid
8%
Chinese Herbal Medicine
8%
Clinician
9%
Cognitive Behavioral Therapy
8%
Dance Therapy
8%
Drug Therapy
9%
Group Trial
6%
Hearing Impairment
8%
Infection
7%
Maturity Onset Diabetes of the Young
8%
Meta-Analysis
15%
Network Meta-Analysis
12%
Neuropathic Pain
8%
Nicotinamide
8%
Placebo
10%
Quality of Life
9%
Randomized Controlled Trial
55%
Rheumatoid Arthritis
8%
Salicylic Acid
8%
Sulfur
8%
Systematic Review
43%
Topical Treatment
5%
Tripterygium wilfordii
8%
Typical Antipsychotic
13%